Sustained nitric oxide release coating using diazeniumdiolate-doped polymer matrix with ester capped poly(lactic-co-glycolic acid) additive

US9566372B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9566372-B2
Application numberUS-201314430545-A
CountryUS
Kind codeB2
Filing dateSep 25, 2013
Priority dateSep 28, 2012
Publication dateFeb 14, 2017
Grant dateFeb 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A polymeric composition includes a polymer matrix having a lipophilic discrete nitric oxide adduct and/or a polymeric nitric oxide adduct associated therewith, by covalent attachment to the polymer matrix and/or by dispersion within the polymer matrix, with the discrete nitric oxide adduct and/or the polymeric nitric oxide adduct being capable of releasing nitric oxide (NO). The polymeric composition further includes an ester capped poly(lactide-co-glycolide) (PLGA) additive to at least one of increase, prolong, and control NO release rates from the lipophilic discrete nitric oxide adduct and/or the polymeric nitric oxide adduct.

First claim

Opening claim text (preview).

What is claimed is: 1. A polymeric composition, comprising: a polymer matrix having at least one of a lipophilic discrete nitric oxide adduct or a polymeric nitric oxide adduct associated therewith, by: covalent attachment to the polymeric matrix; dispersion within the polymeric matrix; or both, with the at least one of the discrete nitric oxide adduct or the polymeric nitric oxide adduct capable of releasing nitrous oxide (NO); and an ester capped poly(lactide-co-glycolide) (PLGA) additive to at least one of increase, prolong, and control NO release rates from the at least one of the lipophilic discrete nitric oxide adduct or the polymeric nitric oxide adduct, the ester capped PLGA additive having a 65:35 ratio of lactic acid monomer to glycolic acid monomer. 2. The polymeric composition as defined in claim 1 wherein the polymer matrix comprises a hydrophobic polymer or a polymer with both hydrophobic and hydrophilic domains. 3. The polymeric composition as defined in claim 1 wherein the polymer matrix comprises at least one of poly(vinyl chloride), silicone rubbers, polyurethanes, polymethacrylates, polyacrylates, polycaprolactone, copolymers thereof, and mixtures thereof. 4. The polymeric composition as defined in claim 1 wherein the polymer matrix further comprises a plasticizer. 5. The polymeric composition as defined in claim 4 wherein the plasticizer comprises at least one of dioctyl sebacate, isopropyl palmitate, isopropyl isosterate, diisooctyl phthalate, o-nitrophenyloctyl ether, and mixtures thereof. 6. The polymeric composition as defined in claim 1 wherein the polymer matrix further comprises chromoionophores. 7. The polymeric composition as defined in claim 1 wherein the polymer matrix comprises poly(vinyl chloride). 8. The polymeric composition as defined in claim 1 wherein the polymer matrix comprises a polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments. 9. The polymeric composition as defined in claim 1 wherein: the polymer matrix is poly(vinyl chloride) (PVC) or a polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments; and the composition includes the lipophilic discrete nitric oxide (NO) adduct, the NO adduct being DBHD/N 2 O 2 (diazeniumdiolated dibutylhexane diamine). 10. The polymeric composition as defined in claim 9 wherein: the polymer matrix includes 65 wt % of: the PVC and dioctyl sebacate (DOS) in a 2:1 ratio; or the polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments; the composition includes 25 wt % DBHD/N 2 O 2 ; and the composition includes 10 wt % of the 6535DLG7E PLGA. 11. A polymeric device, comprising: a base polymer layer; a top polymer layer disposed on the base polymer layer; and at least one active layer between the base polymer layer and the top polymer layer, and the at least one active intermediate layer including the polymeric composition as defined in claim 1 . 12. A polymeric device, comprising: a base polymer layer; a top polymer layer disposed on the base polymer layer; and at least one active layer between the base polymer layer and the top polymer layer, and the at least one active intermediate layer including the polymeric composition as defined in claim 9 . 13. The polymeric device as defined in claim 12 wherein: the base polymer layer is PVC or the polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments; and the top polymer layer is: PVC and dioctyl sebacate (DOS) in a 1:2 ratio; or the polyurethane elastomer with poly(dimethylsiloxane) (PDMS) soft segments. 14. The polymeric device as defined in claim 13 wherein the polymeric device is extracorporeal circuit (ECC) tubing or an intravascular catheter. 15. A method for making an NO-releasing polymeric composition, comprising the steps of: providing a polymer matrix; dispersing at least one of a lipophilic discrete nitric oxide adduct and a polymeric nitric oxide adduct within the polymeric matrix, the at least one of the discrete nitric oxide adduct or the polymeric nitric oxide adduct capable of releasing nitrous oxide (NO); and selecting an ester capped poly(lactide-co-glycolide) (PLGA) additive to at least one of increase, prolong, and control NO release rates from the at least one of the lipophilic discrete nitric oxide adduct or the polymeric nitric oxide adduct, the ester capped PLGA additive having a 65:35 ratio of lactic acid monomer to glycolic acid monomer and having a hydrolysis rate that substantially matches the rate of production of amine sites formed after loss of NO from the at least one of the discrete nitric oxide adduct or the polymeric nitric oxide adduct.

Assignees

Inventors

Classifications

  • Mixtures of macromolecular compounds · CPC title

  • Plasticizers · CPC title

  • Polysiloxanes · CPC title

  • A61L31/16Primary

    Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

  • Homopolymers or copolymers of vinyl chloride · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9566372B2 cover?
A polymeric composition includes a polymer matrix having a lipophilic discrete nitric oxide adduct and/or a polymeric nitric oxide adduct associated therewith, by covalent attachment to the polymer matrix and/or by dispersion within the polymer matrix, with the discrete nitric oxide adduct and/or the polymeric nitric oxide adduct being capable of releasing nitric oxide (NO). The polymeric compo…
Who is the assignee on this patent?
Univ Michigan Regents
What technology area does this patent fall under?
Primary CPC classification A61L31/16. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).